Fentanyl Administered Intraorally for Rapid Treatment of Orthopedic Pain
NCT00685295 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2017-02-09
Summary
Assess whether transbuccal fentanyl provides more rapid relief of orthopedic pain, than does the comparator Percocet
Conditions
- Pain, Fracture, Sprain
Interventions
- DRUG
-
Fentanyl rapid dissolving tablet 100mcg
- DRUG
-
Lansoprazole
lansoprazole 15mg rapidly dissolving tablet
- DRUG
-
Oxycodone
Oxycodone 5/325 mg tablet
Sponsors & Collaborators
-
Massachusetts General Hospital
lead OTHER
Principal Investigators
-
Stephen H Thomas, MD, MPH · Massachusetts General Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-08-31
- Primary Completion
- 2009-02-28
- Completion
- 2009-02-28
Countries
- United States
Study Locations
More Related Trials
-
Clinical Use and Safety of the Fentanyl Transdermal Therapeutic System (TTS) in the Management of Pain in Patients With Cancer
NCT00269763 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for the Management of Breakthrough Pain
NCT00214955 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Investigate of the Effects of Opioid Exposure on the Ability of the Diaphragm Muscle
NCT05856136 ·Status: RECRUITING ·Phase: PHASE4
-
Pain Responses in Patients on Long-Term Opioid Therapy for Chronic Pain
NCT00656942 ·Status: COMPLETED
-
A Study to Evaluate the Safety of D-TRANS Fentanyl With Naltrexone in Adult Patients With Chronic Pain and Who Are Opioid Tolerant
NCT00650182 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Guanfacine on the Reversal of Opioid-induced Hyperalgesia (OIH)
NCT02192398 ·Status: TERMINATED ·Phase: NA
-
Evaluating the Safety and Tolerability of OraVescent Fentanyl for Opioid Tolerant Patients With Noncancer Related Breakthrough Pain
NCT00228605 ·Status: COMPLETED ·Phase: PHASE3
-
Fentanyl Patch Pharmacokinetics in Healthy Adults
NCT02531971 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of the Fentanyl Transdermal Therapeutic System (TTS) in the Management of Pain in Patients With Cancer
NCT00269737 ·Status: COMPLETED ·Phase: PHASE3
-
Narcotic-Free Percutaneous Nephrolithotomy
NCT05924165 ·Status: COMPLETED ·Phase: PHASE4
-
Narcotic Versus Non-narcotic Medication for Pain Management After Wrist/Hand Fractures
NCT03375593 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Compare Patient-controlled Pain Medications Delivered Either Through the Skin or Intravenously
NCT00996177 ·Status: COMPLETED ·Phase: PHASE4
-
Sublingual Versus Endovenous Fentanyl for Pain Treatment in Trauma Patients in the Emergency Room
NCT03080324 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients
NCT00105287 ·Status: COMPLETED ·Phase: PHASE3
-
Safety of Intranasal Fentanyl (PecFent®) in the Treatment of Procedural Pain in the Elderly
NCT02298582 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
To Demonstrate Equivalence in Analgesic Efficacy & Bowel Function Between OXN PR Higher Dose & Lower Dose Tablet Strengths in Subjects With Non-cancer or Cancer Pain
NCT02321397 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Methylnaltrexone vs Naloxegol in the Treatment of Opioid-Induced Constipation
NCT03523520 ·Status: COMPLETED ·Phase: PHASE4
-
Optimizing Subcutaneous FEntanyl titRation: RApid Achievement of Adequate Exposure When Treating Cancer-Related paIn.
NCT06498037 ·Status: RECRUITING ·Phase: PHASE4
-
Phase III Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Chronic Intractable Pain- Assessment of Effectiveness, Safety and Pharmacokinetics
NCT00216684 ·Status: COMPLETED ·Phase: PHASE3
-
Predictors of Postoperative Pain Following Oocyte Retrieval for Assisted Reproduction
NCT03105518 ·Status: UNKNOWN ·Phase: PHASE4
-
Fentanyl for Treatment Pain Caused by Radiotherapy
NCT00523887 ·Status: COMPLETED ·Phase: PHASE4
-
Sublingual Fentanyl for the Management of Breakthrough Pain
NCT02514252 ·Status: TERMINATED ·Phase: PHASE2
-
A Multicentre Study to Evaluate the Safety and Efficacy of AD 923 in Comparison to MSIR for the Treatment of CBP in Subjects
NCT00635063 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy and Safety of Intranasal Morphine for Pain After Elective Orthopedic Surgery
NCT00390039 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Safety and Efficacy Study of Fentanyl Sublingual Spray for the Treatment of Breakthrough Cancer Pain
NCT00538863 ·Status: COMPLETED ·Phase: PHASE3